Cited by 111Schizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchNeural dynamics and brain function

The role of cortical inhibition in the pathophysiology and treatment of schizophrenia

Daskalakis, Zafiris J., Fitzgerald, Paul B., Christensen, Bruce K.·2007·Brain Research Reviews

Abstract

Dysfunctional cortical inhibition (CI) has been suggested as a mechanism through which symptoms of schizophrenia (SCZ) are mediated. Cortical inhibition refers to a neurophysiological process in which gamma-aminobutyric acid (GABA) inhibitory interneurons selectively attenuate the activity of other neurons (e.g., pyramidal neurons) in the cortex. Here we review the neuroanatomic and neurophysiological evidence suggesting CI deficits among persons with SCZ. We also review genetic studies that have linked CI deficits to a polymorphism in the alpha(7)-nicotinic cholinergic receptor, thereby positing that a specific genetic mechanism underlies SCZ-related GABA interneuron dysfunction. We will conclude by reviewing the role of CI as a mechanism mediating the therapeutic action of antipsychotic medications.

Integrity signals

Registry

Crossref · 10.1016/j.brainresrev.2007.09.006

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 151 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Daskalakis, Z. J., Fitzgerald, P. B., & Christensen, B. K.
Affiliations
  • Centre for Addiction and Mental Health (CA)
  • The Alfred Hospital (AU)
Corresponding author
Daskalakis, Zafiris J.
Venue
Brain Research Reviews
Publisher
Elsevier BV
Published
2007-12
Volume
56
Issue
2
Pages
427-442
ISSN
0165-0173 (ISSN-L)
OpenAlex
W2083937777
Cited by
111
References
151
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 9 · 2015: 4 · 2014: 9 · 2013: 9 · 2012: 9
FWCI
1.03
Type
journal article
Language
en
Open access
closed
Locations
  • Brain Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural dynamics and brain function
Keywords
cortical inhibition, schizophrenia, GABAergic interneurons, alpha7 nicotinic acetylcholine receptor, genetic polymorphism, antipsychotic mechanism of action, pyramidal neurons, schizophrenia pathophysiology, schizophrenia treatment
MeSH terms
Animals, Cerebral Cortex, gamma-Aminobutyric Acid, Humans, Interneurons, Schizophrenia, Glutamic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review